WHO is developing a model list of "essential bacteriology and mycology diagnostic tests". This list aims to complement the WHO Essential Diagnostic List (EDL) and to assist countries on the rational placement of bacteriology and mycology diagnostic tests at the different levels of the health care system, from primary care to tertiary-level hospitals, with a particular focus in low- resource settings.
WHO has designed an online survey to gather inputs from microbiologists, infectious diseases clinicians, and laboratory health systems experts. The opinions, values and preferences of these stakeholders are sought on the clinical utility of the tests, their importance for antimicrobial resistance mitigation, technical complexity in performing the tests, and their affordability. A parallel survey addressed to Ministries of Health in all WHO member states is currently ongoing.
Please submit your responses by 17:00 on Monday, 26 February 2024, Central European Time (GMT/UHC +1).
Links to the surveys: